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Introduction
The problem of homograft rejection in man remains unsolved. Any
organ transplanted from one individual to another (except in the
case of identical twins) will be rejected, unless the rejection process
can be abated by some method. Unfortunately, homograft rejection
still occurs all too frequently, and
the toxicity of the drugs used presents problems. However, in other
animal systems the rejection process is directly related to the degree
of antigenic difference between the
donor and the recipient. Recently,
various transplantation centers have
tried to achieve antigenic similarity
between the donor and the recipient
as a means of improving the homograft survival rate. In order to do
this, the antigens of the potential
donors and the recipient are measured in vitro. This is called tissue
typing, or histocompatibility matching.
Humans have been shown to develop antibodies against donor cells
following multiple blood transfusions, multiple pregnancies, organ
homografting and deliberate immunization using repeated injections
of leukocytes or platelets. Such antibodies are cross-reactive in varying percentages of the random
population. A panel of such antibodies or antisera can be tested
against any individual's cells to determine his antigenicity. This can
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then be compared with the results
of typing from other individuals
prior to transplantation.
Antibodies have been identified
against an antigen system known as
HL-A (Table 1) . Tissue typing
studies performed in families have
shown that this system is the result
of antigenic determinants present
on the same pair of chromosomes
at several subloci. However, the
exact interrelationship of these determinants is not fully known. The
use of the HL-A terminology for
the antigens has simplified the exchange of information in this field.
The original terminology of various investigators for these antigens
is also shown in Table 1.
Methods
The methods most commonly
employed in tissue typing are: 1)
lymphocytotoxicity; 2) leukoagglutination; 3) platelet complement
fixation; 4) mixed cell agglutination; 5) immune adherence; and
6) mixed lymphocyte culture. The
lymphocytotoxicity test is the most
commonly employed test and requires viable lymphocytes, a foreign complement source (generally,
rabbit complement), and a battery
of antisera. Cell death occurs if an
antigen-antibody-complement reaction takes place. The most common
method of detecting cell death is a
dye exclusion method. Whereas
dead cells imbibe the surrounding
fluid, including the dye, and appear larger and darker on the inverted phase microscope, living
cells with intact cell membranes
exclude the surrounding fluid and

dye. Terasaki and co-workers have
developed one form of this technique (Terasaki, Vredevoe and
Mickey, 1967; Mittal et al., 1968).
An alternate method of determining cell death is to preincubate the
lymphocytes with 5 1 Cr and then
determine the release of this isotope
as an indication of cell death (Rogentine and Plocinik, 1967).
Reproducibility of these tests is
good, with about a 3% error. However, the tests cannot be done with
cells other than lymphocytes, e.g. ,
kidney cells. An assumption is
made that lymphocytes react similarly to cells from transplantable
organs, i.e., kidney, heart. However, this may not be the case. The
need for viable lymphocytes to perform the test precludes the later
testing of cadaver donors unless the
lymphocytes are specially freezepreserved or maintained in tissue
culture. An outline of the lymphocytotoxicity test employed at the
Medical College of Virginia is
shown in Table 2.
Leukoagglutination is also a
commonly employed method of
tissue typing. In this method leukocytes (whole "huffy coat") are
reacted with the panel of antisera
without any complement (Zmijewski
et al., 1967). An antigen-antibody
reaction leads to agglutination of
the white blood cells. There are a
number of antibodies which are
more reactive in the leukoagglutination test than in the lymphocytotoxicity test, as well as several antibodies which are demonstrable only
by leukoagglutination. However,
these later antibodies presumably
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TABLE 1
Nomenclature of HL-A System Terminology of 3 Investigators
Dausset
HL-Al
HL-A2
HL-A3
HL-A5
HL-A7
HL-AS

van Rood

Payne

LAl
SA
LA3
DAS
7C
7D
4A
4B
4C

LAI
LA2
LA3

11

1 (MAC)
12
5
10

8

4D
7D

TABLE 2
Outline of Lymphocytotoxicity Test
1. Prepare pure suspension of lymphocytes
a. Freshly drawn specimen
b . Mailed specimen
2. Add lymphocytes to previously prepared trays of
110 antisera + recipient's sera
3. Add pooled rabbit complement
4. Add eosin and formalin
5. Allow cells to resettle and prepare trays for readings
6. Read microtest trays on inverted phase microscope
7. Evaluate typing

45 min

60 min
60-120 min
30 min
15 min
15 min
4-5 hr
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Fig. 1-The mixed cell agglutination test. See text.
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are not recognizing important transplant antigens.
The platelet complement fixation
test requires platelets, complement,
and a battery of antisera (Shulman
et al., 1964). This test is no longer
widely employed. Dausset (1969)
recently described new antigenantibody reactions-related to the
HL-A system-which occurred with
this test but were not demonstrable
in the lymphocytotoxic or leukoagglutination tests.
All three of these tests require a
large panel of antisera. Whereas
erythrocyte typing requires only a
single anti-A serum and a single
anti-B serum. This is because the
transplantation antigens as well as
the antisera employed for detecting
these antigens are poorly defined.
The three other techniques of
tissue typing are not widely employed at present but may have
wider application in the future.
Mixed cell agglutination requires
that the target cells be grown in
tissue culture monolayers (Milgrom
et al., 1966). However, any cell
line capable of being grown in tissue culture may be used . Attempts
to employ this test with dispersed,
fresh cells, cryostat sections, or
fresh tissue slices have been unsuccessful. This test requires a special
indicator cell system consisting of
human erythocytes precoated with
an antibody directed against human
erythrocytes and an anti-human antibody capable of reacting with both
the first antibody and the test antisera. At the Medical College of
Virginia this indicator system consists of Rh+ erythrocytes precoated
with anti-Rh antibody and a goat
anti-human antibody. The test antiserum is layered over the monolayer of target cells, followed by
thorough washing and the addition
of the coated indicator cell system.
Agglutination of the indicator cell
system indicates that the test antiserum has reacted with the target
cell (Fig. 1) .
The immune adherence test requires a cell suspension, potent
complement source, and human
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erythrocytes (Nelson, 1956). It
can be performed with various
types of cells-dead or alive. If an
antigen-antibody-complement reaction takes place, the erythrocyte indicator cells will adhere to the target cell. The immune adherence
and mixed cell agglutination tests
are much more sensitive than the
previously described tests. The
mixed lymphocyte culture technique
has been described in full by Bach
(1966).
In the immune adherence test a
comparison of reactivity of lymphocytes and kidney cells from one
individual against the same antisera revealed these results in the
five individuals studied: 37 negative reactions against lymphocytes
and kidney cells, 15 positive reactions against lymphocytes and
kidney cells, 29 reactions in which
the antisera reacted positively with
kidney cells and negatively with
lymphocytes, and four instances in
which the reverse relationship
existed. This is presumptive evidence for an antigenic difference
between kidney cells and lymphocytes. Whether or not it is a qualitative or quantitative difference is
not shown by these data. At any
rate, the data are against the assumption that, by typing leukocytes, one can determine the full
antigenicity of an organ to be transplanted.
A similar discrepancy has been
demonstrated by testing lymphocytes and kidney cells from the
same individual-through use of
the lymphocytotoxicity and mixed
cell agglutination tests, respectively.
In retesting an individual's cells
against an antiserum in which the
lymphocytotoxicity reaction was
negative and the mixed cell agglutination reaction positive, the difference in reactivity appeared to be
quantitative, as prior absorption
with the individual's leukocytes removed the reactivity against kidney
cells, despite there originally being
no reactivity demonstrable by lymphocytotoxicity testing.
Since the antigenic determinants
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TABLE 3
Examples of Lymphocyte Typing Results " A" Match
Example 1
HL-Al HL-A2 HL-A3 HL-A7
Donoc
+
+
+
Recipient
+
+
+
4 of 100 sera "killed" donor's but not recipient's cells

HL-AS

4A

+

+

4B

4C

+

+

Example 2
HL-AI HL-A2 HL-A3 HL-A7 HL-AS 4A 4B 4C
Donor
+
Recipient
+
+
+
+ +
1 of 100 sera "killed" donor's but not recipient's cells. All of above differences
in antigenic groups are in the "minor direction."

for the HL-A system occur on the
same pair of chromosomes, there
is a 25 % chance that a sibling will
be identical with any other sibling
for the HL-A system. By tissue typing a family, it can be determined
which individuals share 0, 1, or
both chromosomes. Amos et al.
( 1969) have shown that skin grafts
between nonimmunosuppressed siblings known to be identical for
the HL-A system have a mean survival of about 25 days. The failure
of permanent graft take might indicate that there are other antigenic
systems present on other chromosomes which are not yet defined.
Detailed absorption studies have
been done in our laboratory to
demonstrate the presence of HL-A
antigens in various human tissues,
i.e., kidney, liver, heart, blood vessels, lung, skin, pancreas, ureter
and fat. Kidney and liver tissue

were found to contain all eight of
the well recognized HL-A antigens,
whereas fat had no HL-A antigens.
The other tissues studied were not
tested for all eight antigen groups
but did contain every antigen for
which tests were run (Rolley, Williams and Hume, 1968). These
studies were sufficiently controlled
to exclude the possibilities of nonspecific loss of antibody activity
through surface absorption phenomena or by anti-complementary factors. The studies indicated that the
HL-A system is widely distributed
in human organs, but this does not
preclude the possibility that tissues
possess important histocompatibility antigens not detectable on leukocytes. The possibility of such tissue transplantation antigens being
poorly expressed on leukocytes has
been shown in the ABO erythrocyte system.
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Histocompatibility Matching
Of the six tissue typing techniques discussed above, only mixed
lymphocyte culture involves direct
interaction between donor and recipient cells. The other five tests all
use a comparison of results against
a panel of antisera. A histocompatibility match may be reported on
an A, B, C, or D scale. The terms
A and B are comparable to the
terms matched or compatible; the
terms C and D are comparable to
the terms mismatched or incompatible. Table 3 shows two examples of an A match. In the upper
example of that table, the antigenicity of the donor and the recipient
for these eight antigens is the same.
However, a great deal of attention
is also given to individual serum
reactions, since not all sera have
been classified for one of these particular antigen groups. In this example 4% of the sera reacted
with antigens of the donor but not
of the recipient. Theoretically, the
recipient is capable of reacting to
such foreign antigens.

In the second example of an A
match in Table 3, the recipient bas
more antigen groups than the
donor. At our present level of
knowledge, this is assumed not to
affect graft survival and therefore,
the example is not considered a
mismatch; but rather an A match.
Table 4 shows an example of a
B match in which no recognized
antigen groups are present on donor
cells but absent on recipient cells.
However, more than 5 % of the
individual sera detected antigens on
donor but not recipient cells; hence,
this match is rated B rather than A.
Table 4 also shows an example
of a C match in which a well recognized antigen group is present on
donor cells but absent on recipient
cells. A D match (Table 4) indicates a donor-to-recipient mismatch
of two antigen groups.

auto-antibodies, such as the antiglomerular basement membrane
antibodies. To look for preformed
antibodies against histocompatibility antigens, it is necessary to perform a cross match test using the
recipient's serum and donor's cells.
This can be done by any one of
the five tissue typing methods discussed in this paper. If preformed
antibodies are found and a transplant performed, there is a great
probability that the transplant will
be rejected very quickly. A discussion of the detection of autoantibodies is beyond the scope of
this paper.
At present, bistocompatibility
matching is an inexact science, and
there are undoubtedly many histocompatibility antigens either poorly
defined or undefined. With further
definition of such antigens, improvement can be expected in the
correlation of tissue typing with
homograft function and survival.
Further work also needs to be done
to determine which method of tissue typing is best.

Preformed Antibodies
Tissue typing tests determine
neither the presence of preformed
antibodies against donor antigens,
nor the presence of organ-specific

TABLE 4
Examples of Lymphocyte Typing Results
HL-Al

HL-A2

"B" Match
HL-A3
HL-A7

+
+
Donor
Recipient
+
+
12 of 100 sera "killed" donor's but not recipient's sera.

Donor
Recipient

---I HL-A l

l

HL-AS

4A

4B

4C

HL-A8

4A

4B

4C

+
+
"C" Match

HL-A2

HL-A3

HL-A7

+
+

+

+
+

+
+

1 group mismatch in "major direction."
"D" Match
HL-Al
Donor
Recipient

ff

2 group mismatches in "major direction."

HL-A3

+
+

ITJ

HL-AS

4A

+
+

4B

4C

+
+
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